Barale F, Milleret P, Gillet M, Boillot A, Prieur C, Leconte M, Egreteau J P, Henry J C, Gibey R
Ann Anesthesiol Fr. 1975 Nov;16(7):553-62.
A post-operative use of the calorico-nitrogenous mixture: Trivé 1000 was carried out in 25 patients after digestive surgery. The prescribed dose of this lipidic emulsion was 1,36 1 for an average period of four days. A study of the results led to establish the following facts:--a 55 p. cent increase in the nitrogen retention in comparison with a control series of ten patients and from (J o) the day of the intervention to (J F) the day when the treatment was stopped. Besides, the duration of the treatment did not seem to modify this balance, at least within the limits of the period of use. On the other hand, the quantity of EB 51 was a determining factor since 2000 ml were necessary to obtain a positive nitrogen balance (+ 0.96 g).--a very small rise in the amino-acid serous rate. It appeared in 14 patients and, supplied by EB 51, 3 other amino-acids increased their proportion spontaneously (Asp.--Gluc.--Tau.).--a reduction of the rate of 5 amino-acids, one of which, however, (Arginine) was being supplied by the drip. The variations were never statistically significant but for the Phenylalanine rate increase.--a non-systematic variation in the blood proteids that decreased as far as total proteids and albumin were concerned and that increased as far as globulins alpha1 and alpha2 were concerned.--Finally, no variations in the serous graphic record of lipid levels were noted, neither in the average of figures, nor in the analyses carried out after each bottle. Besides, it must be added that the tolerance of the product was excellent both on a general level (very few cases of intolerance: 4) and on the level of the plasma turbidimetry which did not reveal and chylomicrons except in one case. Therefore Trivé 1000 proved to be an interesting nutrient combinatin quite suited to a parenteral feeding because of its high caloric power. The necessity of a calories/g/nitrogen ratio from 100 to 200 corresponding to 2000 ml of EB 51 was once more evidenced. Therefore such a dose (for lack of a protein assimilation) allows for a nitrogen retention important enough to prevent an excessive consumption of the body proteinic reserves. Such doses are perfectly tolerated both on the general and metabolic levels (mainly on the lipometabolic one).
对25例消化手术后患者进行了术后使用卡洛里 - 含氮混合物Trivé 1000的治疗。这种脂质乳剂的规定剂量为1.36升,平均使用期为四天。对结果的研究得出了以下事实:与由10名患者组成的对照组相比,从干预当天(J o)到治疗停止当天(J F),氮潴留增加了55%。此外,治疗持续时间似乎并未改变这种平衡,至少在使用期限范围内如此。另一方面,EB 51的量是一个决定性因素,因为需要2000毫升才能实现正氮平衡(+ 0.96克)。——血清氨基酸率有非常小的升高。14例患者出现这种情况,并且由EB 51提供的另外3种氨基酸其比例自发增加(天冬氨酸、葡萄糖、牛磺酸)。——5种氨基酸的比例降低,然而其中一种(精氨酸)是通过滴注提供的。除苯丙氨酸比例增加外,这些变化在统计学上均无显著意义。——血液蛋白质出现非系统性变化,就总蛋白和白蛋白而言降低,而就α1和α2球蛋白而言增加。——最后,无论是在数据平均值方面,还是在每瓶输注后进行的分析中,均未发现血脂水平的血清图谱记录有变化。此外,必须补充的是,该产品的耐受性总体上极佳(不耐受情况极少:4例),在血浆比浊法方面也是如此,除1例情况外未发现乳糜微粒。因此,Trivé 1000被证明是一种有趣的营养组合,因其高热量值非常适合肠外营养。再次证明了热量/克/氮比值为100至200(对应2000毫升EB 51)的必要性。因此,这样的剂量(由于缺乏蛋白质同化作用)能实现足够重要的氮潴留,以防止身体蛋白质储备过度消耗。这种剂量在总体和代谢水平(主要是脂代谢水平)上均具有良好的耐受性。